Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Various parameters in children with chronic kidney disease and control subjects

From: Genetic polymorphism of ACE and the angiotensin II type1 receptor genes in children with chronic kidney disease

 

CT

(n = 32)

MHD

(n = 44)

Controls

(n = 70)

P value

Age(Years)

9.14 ± 7.59

10.62 ± 3.49

10.7 ± 4.51

0.14

Gender (M/F)

15 (46.88%)/17(53.12%)

24(54.55%)/20(45.45%)

40(57.14%)/30(42.86%)

0.30

BMI (kg/m 2 )

17.64 ± 1.17

18.89 ± 3.00

20.60 ± 1.44

0.71

SBP (mmHg)

98.66 ± 6.66

125.13 ± 16.36 b*

95.54 ± 9.70

0.01

Indexed SBP

0.90 ± 0.85

1.04 ± 0.14 b**

0.73 ± 0.05

0.001

DBP (mmHg)

64.66 ± 6.67

83.13 ± 12.76 b*

61.55 ± 10.10

0.01

Indexed DBP

0.90 ± 0.0.86

1.00 ± 0.10 b**

0.72 ± 0.05

0.001

Creatinine

(mg/dl)

3.93 ± 3.75 a*

6.30 ± 1.45 b**

0.73 ± 0.33

0.002

Predialysis urea, (mg/dl)

51.12 ± 10.45 a*

70.56 ± 19.61 b*

7.76 ± 2.53

0.02

e-GFR, ml/min/1/1.73 m2

15.41 ± 1.76 a**

11.30 ± 3.35 b**

86 ± 8.8

0.003

Dialysis, Yrs

 

2.73 ± 1.58

  

Kt/V

 

1.68 ± 0.40

  

Total cholesterol

(mg/dl)

164.44 ± 50.10ac**

192.04 ± 50.37 b*

161.31 ± 18.75

0.06

Triglycerides

(mg/dl)

160.78 ± 57.33 a**

146.00 ± 65.98 b**

63.31 ± 17.35

0.001

HDL- cholesterol (mg/dl)

21.35 ± 1.17a*

27.33 ± 9.87 b*

40.55 ± 7.83

0.01

hs-CRP

(mg/dl)

3.04 ± 3.24

3.62 ± 3.97 b*

1.35 ± 0.65

0.04

CK-MB (ng/ml)

6.23 ± 2.46 a*

5.26 ± 1.14

4.20 ± 0.20

0.04

ACE-activity(IU/l)

53.02 ± 22.44

70.47 ± 53.73 b**

30.11 ± 8.85

0.03

Left ventricular mass index (g/m 2.7 )

49 ± 5.20 a*

52.86 ± 10.10 b*

35.10 ± 8.12

0.04

Severe left ventricular hypertrophy, n (%)

6(18.75%)

25(56.82%)

  
  1. Data was evaluated by ANOVA test. Values were presented as means ± SD or percentage as applicable. CT = conservative treatment, MHD = maintenance hemodialysis, ACE = angiotensin converting enzyme, BMI = body mass index, SBP = systolic blood pressure, DBP = diastolic blood pressure, eGFR = estimated glomerular filtration rate, Kt/V = adequacy of hemodialysis, hs-CRP = high sensitivity C-reactive protein, CK-MB = creatine kinase-MB fraction. a*P < 0.05 or a**P < 0.01 vs. controls and CTb, *P < 0.05 or b**P < 0.01 vs. controls and MHD and, cP < 0.05 vs. CT and MHD.